Interleukin-6 sensitizes TNF-α and TRAIL/Apo2L dependent cell death through upregulation of death receptors in human cancer cells
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1868 (7) , 119037
Abstract
No abstract availableKeywords
Funding Information
- University of Tokyo
- Toray Industries
This publication has 41 references indexed in Scilit:
- Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cellsOncogene, 2011
- New insights into apoptosis signaling by Apo2L/TRAILOncogene, 2010
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination StudiesPharmacological Reviews, 2006
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- TNF-R1 Signaling: A Beautiful PathwayScience, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Mechanisms and Functions of Cell DeathAnnual Review of Cell Biology, 1991
- Host defense against infections and inflammations: Role of the multifunctional IL-6/IFN-β2 cytokineCellular and Molecular Life Sciences, 1989